Abstract
• Background: No study of the radiosensitivity of uveal melanoma cells and their survival curve has been published. The purpose of this study was to investigate the sensitivity to different single radiation doses of SP6.5, a human uveal melanoma cell line. • Methods: Cells were irradiated with cobalt-60 at doses from 0 to 1200 cGy. Radiosensitivity was measured by three methods: soft-agar bilayer assay, tritiated thymidine incorporation, and bromodeoxyuridine (BrdU) incorporation. • Results: The soft-agar bilayer assay, by assessing the colony-forming units, showed that the D 1 value was 470 cGy, the D q value was 400 cGy, and the n value exceeded 10, thus indicating a broad, shoulder and relative radioresistance. The doubling time as estimated by [3H]thymidine incorporation was unaffected at doses below 600 cGy, another indication of radioresistance. BrdU incorporation revealed no significant increase between 0 and 1000 cGy, indicating that the cell cycle was not interrupted. • Conclusion: Cell survival, doubling time, and cell phases are parameters of growth kinetics, and the results suggest that SP6.5 is radioresistant and virtually unaffected by single radiation doses lower than 600 cGy. Our data parallel published data for cutaneous melanomas.
Similar content being viewed by others
References
Beisker W, Dolbeare F, Gray JW (1987) An improved immunocytochemical procedure for high-sensitivity detection of incorporated bromodeoxyuridine. Cytometry 8:235–239
Char DH, Huhta K, Waldman F (1989) DNA cell cycle studies in uveal melanoma. Am J Ophthalmol 107:65–72
Cochran AJ, Wen DR (1985) S-100 protein as a marker for melanotic and other tumors. Pathology 17:340–345
Hamburger AW, Salmon SE (1977) Primary bioassay for human tumor stem cells. Science 87:461–463
Hornsey S (1978) The relationship between total dose, number of fractions and fraction size in the response to malignant melanoma in patients. Br J Radiol 51:906–909
Johns HE (1969) In: Johns HE, Conningham JR (eds) The physics of radiology. Thomas, Springfield, Ill, pp 686–701
Landry J, Marceau N (1979) Cell growth recovery after treatment at various supraoptimal temperatures. Cancer Res 39:1218–1223
Markoe AM, Brady LW, Shields JA, Augsburger JJ, Micaily B, Damster JI, Day JL, Gamel JW (1985) Malignant melanoma of the eye: treatment of posterior uveal lesions by Co-60 plaque radiotherapy versus enucleation. Radiology 156:801–803
Pizzarallo DJ (1982) Cell-survival curves. In: Pizzarello DJ, Witcofski RL (eds) Medical radiation biology. Lea and Febiger, Philadelphia, pp 94–102
Onoda JM, Piechocki MP, Honn KV (1992) Radiation-induced increase in expression of the αIIbβ3 integrin in melanoma cells: effects on metastatic potential. Radiat Res 130:281–288
Rider WD, Palmer JA, Mahoney LJ, Robertson CT (1977) Preoperative irradiation in operable cancer of the rectum: report of the Toronto Trial. Can J Surg 20:335–338
Rofstad EK (1990) PLD-repair in human melanoma xenografts following single dose and fractionated irradiation. Br J Cancer 61:856–860
Rousseau AP, Deschênes J, Pelletier G, Tremblay M, Larochelle-Belland M (1989) Effect of pre-enucleation radiotherapy on the viability of human choroidal melanoma cells. Can J Ophthalmol 24:10–14
Soulières D, Rousseau A, Deschênes J, Tremblay M, Tardif M, Pelletier G (1991) Characterization of gangliosides in human uveal melanoma cells. Int J Cancer 49:498–503
Thompson SP, Moon TE, Meyskens FL Jr (1984) Kinetics of clonogenic melanoma cell proliferation and the limits on growth within a bilayer agar system. J Cell Physiol 121:114–124
Trott KR, Von Lieven H, Kummermehr J, Skopal D, Lukacs S, Braun-Falco O (1981) The radiosensitivity of malignant melanomas. 1. Experimental studies. Int J Radiat Oncol Biol Phys 7:9–13
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Soulières, D., Rousseau, A., Tardif, M. et al. The radiosensitivity of uveal melanoma cells and the cell survival curve. Graefe's Arch Clin Exp Ophthalmol 233, 85–89 (1995). https://doi.org/10.1007/BF00241477
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00241477